BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  AbbVie Reports Full-Year and Fourth-Quarter 2022 Financial Results

  AbbVie (NYSE:ABBV) announced financial results for the fourth quarter and full year ended December 31, 2022.

  February 9, 2023

   · 

  27 min read
• Deals

  aTyr Pharma Announces Pricing of Public Offering of Common Stock

  aTyr Pharma, Inc. today announced the pricing of its previously announced underwritten public offering of 22,225,000 shares of its common stock at a public offering price of $2.25 per share.

  February 9, 2023

   · 

  5 min read
• New Publication Highlights geneType’s Ability to Detect Breast Cancer Earlier and Provide Data for Risk Stratification

  Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) – a global leader in genomics-based tests in health, wellness and serious disease – is pleased to announce the publication of a new research paper in the peer-reviewed journal Breast Cancer Research and Treatment.

  February 9, 2023

   · 

  6 min read
• Biotech Bay

  Nkarta to Participate at Upcoming Investor Conferences

  Nkarta, Inc. today announced its participation at three upcoming investor conferences.

  February 9, 2023

   · 

  1 min read
• Pharm Country

  Nuvectis Pharma Announces a Publication in The Journal of Experimental Medicine for NXP900 in an In-Vivo Model of Metastatic Castration Resistant Prostate Cancer (“mCRPC”) with Acquired Resistance to Enzalutamide

  Nuvectis Pharma, Inc. today announced a publication in the Journal of Experimental Medicine (“JEM”) for NXP900 in an in-vivo model of metastatic castration resistant prostate cancer.

  February 9, 2023

   · 

  4 min read
• Business

  First Prescription for COSELA® (trilaciclib) Issued in China

  Simcere Pharmaceutical Group Limited announce a significant milestone in the fight against cancer with the issuance of the first prescription for COSELA® (trilaciclib) in China.

  February 9, 2023

   · 

  6 min read
• Business

  Corium Pharma Solutions Names Two Industry Veterans to its Executive Team

  Corium Pharma Solutions, Inc. has named Kevin Ostrander as Chief Business Officer and Dr. Niraj Vasisht as Chief Technology Officer.

  February 9, 2023

   · 

  5 min read
• Biotech Beach

  Regulus Therapeutics to Present at the SVB Securities Global Biopharma Conference

  Regulus Therapeutics Inc today announced that Jay Hagan, President and Chief Executive Officer of Regulus, will present at the SVB Securities Global Biopharma Conference.

  February 9, 2023

   · 

  3 min read
• Biotech Bay

  TIOGA CARDIOVASCULAR, A SHIFAMED PORTFOLIO COMPANY, CLOSES $30M IN SERIES C FINANCING

  Tioga Cardiovascular, a Shifamed portfolio company that aims to redefine structural heart valve replacement, announced today the first closing of its $30M Series C financing.

  February 9, 2023

   · 

  3 min read
• Pharm Country

  Ocean Biomedical and Aesther Healthcare Acquisition Corp. Announce the Award of New Patents for Novel Monospecific and Bispecific Antibodies that Suppress Multiple Cancer Types

  Ocean Biomedical and Aesther Healthcare Acquisition Corp. announced that Scientific Co-founder Dr. Jack A. Elias has been awarded multiple patents for his discoveries related to suppressing tumors by regulating CHI3L1 and several connected pathways.

  February 9, 2023

   · 

  10 min read